Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Morepen Laboratories secures NMPA approval for Loratadine API in China
The company expands its global footprint with regulatory approval from China’s NMPA, reinforcing its leadership in antihistamine…
Panacea Biotec announces completion of tenure of Director Narotam Kumar Juneja
The company confirms the conclusion of Narotam Kumar Juneja’s tenure as Non-Executive Non-Independent Director and Whole-Time…
LuNGS Alliance launches free lung NGS biomarker testing for lung cancer patients in India
The initiative, driven by Cancer Research and Statistic Foundation and supported by AstraZeneca, Pfizer and Roche, and lab partner…
HRV Global Life Sciences delivers Indian anti-diabetic drugs to Mendoza, Argentina
The scope of this initiative is being extended to more provinces of Argentina and additional therapeutic segments, including…
USC-licensed startup NeOnc Technologies gets NASDAQ listing
Unveils plans to expand clinical trials in India for its proprietary drug called NEO100, an ultra-purified perillyl alcohol with…
SPARC announces submission of IND application for SBO-154 to USFDA
SBO-154 set to enter global Phase 1 clinical trial for treatment of advanced solid tumours
Bio-Thera, Dr. Reddy’s partner to commercialise BAT2206, a proposed Stelara Biosimilar, and BAT2506,…
Under the agreement, Bio-Thera will develop, manufacture, and supply BAT2206 and BAT2506. Dr. Reddy’s will seek regulatory…
Cohance Lifesciences, Suven Pharmaceuticals merger sanctioned by the NCLT
The Company expects to complete the amalgamation process by Q1FY26
Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection gains USFDA fast track…
Sanofi is planning a phase 1/2 randomised, clinical study designed to evaluate the immunogenicity and safety of the chlamydia…
Akums installs 600 kWp rooftop solar power plant to enhance sustainability efforts
Haridwar-based facility to generate over 7.5 lakh units of solar power annually, reducing carbon footprint and energy costs